1 recruiting, 1 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 1, Terminated 1 |
Follow Tumor Imaging: new trials by email Literature Review of Tumor Imaging trials Research Report on Tumor Imaging
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Glofitamab With Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma Obinutuzumab, Glofitamab, Pirtobrutinib - Mantle Cell Lymphoma | Phase 2 | Recruiting | University of California, San Francisco | 30 | 2024-06-11 | 2026-10-01 |
| Disulfiram-Copper Gluconate in Met Pancreas Cancer w Rising CA19-9 on Abraxane-Gemzar, FOLFIRINOX or Gemcitabine Safety Laboratories, AE Assessment, Physical Exam - Metastatic Pancreatic Cancer | Phase 2 | Terminated | HonorHealth Research Institute | 1 | 2019-10-17 | 2023-10-18 |
Lymphoma, Mantle-Cell (1) · Pancreatic Neoplasms (1)
HonorHealth Research Institute (1) · University of California, San Francisco (1)
United States (2)
Gayle Jameson, ACNP-BC (1) · Madhav Seshadri, MD (1)